Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
6.08
-0.30 (-4.70%)
At close: Nov 20, 2024, 4:00 PM
5.96
-0.12 (-2.04%)
After-hours: Nov 20, 2024, 5:50 PM EST
Larimar Therapeutics Market Cap
Larimar Therapeutics has a market cap or net worth of $389.22 million as of November 21, 2024. Its market cap has increased by 190.03% in one year.
Market Cap
389.22M
Enterprise Value
189.60M
1-Year Change
190.03%
Ranking
Category
Stock Price
$6.10
Market Cap Chart
Since June 19, 2014, Larimar Therapeutics's market cap has decreased from $410.90M to $389.22M, a decrease of -5.28%. That is a compound annual growth rate of -0.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 407.10M | 103.75% |
| Dec 29, 2023 | 199.80M | 11.81% |
| Dec 30, 2022 | 178.70M | -6.49% |
| Dec 31, 2021 | 191.10M | -41.88% |
| Dec 31, 2020 | 328.80M | 692.29% |
| Dec 31, 2019 | 41.50M | -77.26% |
| Dec 31, 2018 | 182.50M | 43.70% |
| Dec 29, 2017 | 127.00M | 46.14% |
| Dec 30, 2016 | 86.90M | -49.27% |
| Dec 31, 2015 | 171.30M | -75.54% |
| Dec 31, 2014 | 700.30M | 70.43% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KalVista Pharmaceuticals | 401.90M |
| Rigel Pharmaceuticals | 400.57M |
| Canopy Growth | 398.27M |
| Sangamo Therapeutics | 396.43M |
| Sonida Senior Living | 395.02M |
| Akebia Therapeutics | 392.73M |
| enGene Holdings | 390.46M |
| Tango Therapeutics | 386.70M |